SNSE insider transactions
Sensei Biotherapeutics Inc. (SNSE) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for SNSE
- Chief Financial Officer Stephenson Brian C bought $326,127 worth of shares (13,634 units at $23.92) (SEC Form 4)4 - Faeth Therapeutics, Inc. (0001829802) (Issuer)
- Chief Financial Officer Stephenson Brian C bought $401,269 worth of shares (15,641 units at $25.65) (SEC Form 4)4 - Faeth Therapeutics, Inc. (0001829802) (Issuer)
- Chief Financial Officer Stephenson Brian C bought $405,921 worth of shares (17,413 units at $23.31) (SEC Form 4)4 - Faeth Therapeutics, Inc. (0001829802) (Issuer)
- President and CEO Parikh Anand Kiran bought $55,447 worth of shares (2,806 units at $19.76) and exercised 53,465 shares at a strike of $1.16, increasing direct ownership by 7% to 817,699 units (SEC Form 4)4 - Faeth Therapeutics, Inc. (0001829802) (Issuer)
- SEC Form 3 filed by new insider Stephenson Brian C3 - Faeth Therapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Ramasastry Saira4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- President and CEO Parikh Anand Kiran converted options into 761,428 shares (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 3 filed by new insider Ramasastry Saira3 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Director Hahn Stephen M. converted options into 44,763 shares (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 3 filed by new insider Hahn Stephen M.3 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Amendment: SEC Form 4 filed by President and CEO Parikh Anand Kiran4/A - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by President & PEO Gerry Christopher4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Donenberg Phillip B.4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Holmen Bob4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Large owner Cambrian Biopharma Inc sold $500,543 worth of shares (25,000 units at $20.02), decreasing direct ownership by 16% to 130,142 units (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Large owner Peyer James sold $500,543 worth of shares (25,000 units at $20.02), decreasing direct ownership by 16% to 130,142 units (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Large owner Millennium Management Llc bought $141,364 worth of shares (4,215 units at $33.54) and sold $538,114 worth of shares (17,076 units at $31.51) (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Large owner Millennium Management Llc bought $818,257 worth of shares (30,585 units at $26.75) and sold $89,390 worth of shares (3,250 units at $27.50) (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Sensei Biotherapeutics Inc.4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Craver Josiah4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Donenberg Phillip B.4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Parikh Anand Kiran4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 3 filed by new insider Parikh Anand Kiran3 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Donenberg Phillip B.4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 3 filed by new insider Donenberg Phillip B.3 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Large owner Cambrian Biopharma Inc exercised 395 shares at a strike of $6.40 and sold $54,575 worth of shares (6,612 units at $8.25) (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Large owner Peyer James sold $54,575 worth of shares (6,612 units at $8.25) and exercised 395 shares at a strike of $6.40 (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Large owner Cambrian Biopharma Inc sold $232,690 worth of shares (21,295 units at $10.93) (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Large owner Peyer James sold $232,690 worth of shares (21,295 units at $10.93) (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- New insider Gerry Christopher claimed ownership of 1,574 shares (SEC Form 3)3 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Large owner Cambrian Biopharma Inc4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Ricks Thomas G4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Humer Kristian4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Peyer James4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Holmen Bob4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Ringo William R4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- PRESIDENT AND CEO Celebi John covered exercise/tax liability with 5,558 shares, decreasing direct ownership by 5% to 105,862 units (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- CHIEF SCIENTIFIC OFFICER Van Der Horst Edward covered exercise/tax liability with 2,276 shares, decreasing direct ownership by 4% to 59,794 units (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Chief Business Officer Krebs Stephanie4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Principal Financial Officer Craver Josiah4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Celebi John4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Van Der Horst Edward4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Principal Financial Officer Craver Josiah4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Celebi John4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by CHIEF SCIENTIFIC OFFICER Van Der Horst Edward4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Chief Business Officer Krebs Stephanie4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 3 filed by new insider Craver Josiah3 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Large owner Cambrian Biopharma Inc4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Peyer James4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Holmen Bob4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director English Jessie4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Humer Kristian4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Ringo William R4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Ricks Thomas G4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Director Vojta Deneen4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 3 filed by new insider Gaiero David G3 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Van Der Horst Edward covered exercise/tax liability with 2,843 shares, decreasing direct ownership by 5% to 56,070 units (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Celebi John covered exercise/tax liability with 5,891 shares, decreasing direct ownership by 5% to 105,420 units (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- Colgan Erin covered exercise/tax liability with 3,627 shares, decreasing direct ownership by 5% to 67,462 units (SEC Form 4)4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)
- SEC Form 4 filed by Krebs Stephanie4 - Sensei Biotherapeutics, Inc. (0001829802) (Issuer)